SERUM MARKERS OF BONE REMODELING IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER AND BONE METASTASES

被引：0
|
作者：
Lumachi, F. [1 ]
Mazza, F. [2 ]
Del Conte, A. [2 ]
Chiara, G. B. [2 ]
Basso, S. M. M. [2 ]
机构：
[1] Univ Padua, Sch Med, Dept Surg Oncol & Gastroenterol, Padua, Italy
[2] S Maria degli Angeli Hosp, Pordenone, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
126P
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [1] RELATIONSHIP BETWEEN BONE SERUM MARKERS IN PATIENTS WITH BONE METASTASES FROM NON-SMALL CELL LUNG CARCINOMA
    Loriggiola, Laura
    Lumachi, Franco
    Chiara, Giordano Bruno
    Basso, Stefano Maria Massimiliano
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S199 - S199
  • [2] Zoledronic acid treatment in advanced non-small cell lung cancer patients with bone metastases
    Zhengbo Song
    Yiping Zhang
    Medical Oncology, 2014, 31
  • [3] Diagnostic and prognostic validity of serum bone turnover markers in bone metastatic non-small cell lung cancer patients
    Wang, Zhiyu
    Lu, Yaohong
    Qiao, Dan
    Wen, Xiaoting
    Zhao, Hui
    Yao, Yang
    JOURNAL OF BONE ONCOLOGY, 2015, 4 (03): : 85 - 91
  • [4] Clinicopathological Factors in Non-Small Cell Lung Cancer Patients with Bone Metastases
    Ulas, Arife
    Bilici, Ahmet
    Durnali, Ayse
    Tokluoglu, Saadet
    Akinci, Sema
    Silay, Kamile
    Oksuzoglu, Berna
    Alkis, Necati
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S535 - S535
  • [5] Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
    Landi, Lorenza
    D'Inca, Federica
    Gelibter, Alain
    Chiari, Rita
    Grossi, Francesco
    Delmonte, Angelo
    Passaro, Antonio
    Signorelli, Diego
    Gelsomino, Francesco
    Galetta, Domenico
    Giannarelli, Diana
    Parra, Hector Soto
    Minuti, Gabriele
    Tiseo, Marcello
    Migliorino, Maria Rita
    Cognetti, Francesco
    Toschi, Luca
    Bidoli, Paolo
    Piantedosi, Francovito
    Calabro, Luana
    Cappuzzo, Federico
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [6] The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases
    S. Rinaldi
    M. Santoni
    G. Leoni
    I. Fiordoliva
    G. Marcantognini
    T. Meletani
    G. Armento
    D. Santini
    T. Newsom-Davis
    M. Tiberi
    F. Morgese
    M. Torniai
    M. Bower
    Rossana Berardi
    Supportive Care in Cancer, 2019, 27 : 1255 - 1261
  • [7] The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases
    Rinaldi, S.
    Santoni, M.
    Leoni, G.
    Fiordoliva, I.
    Marcantognini, G.
    Meletani, T.
    Armento, G.
    Santini, D.
    Newsom-Davis, T.
    Tiberi, M.
    Morgese, F.
    Torniai, M.
    Bower, M.
    Berardi, Rossana
    SUPPORTIVE CARE IN CANCER, 2019, 27 (04) : 1255 - 1261
  • [8] Detection of bone metastases in non-small cell lung cancer (NSCLC).
    Irving, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 663S - 663S
  • [9] Bone Metastases in Non-Small Cell Lung Cancer: A Retrospective Study
    Bagri, Puneet K.
    Samdariya, Saurabh
    Pareek, Puneet
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S768 - S768
  • [10] Bone metastases in non-small cell lung cancer: a narrative review
    Knapp, Brendan J.
    Devarakonda, Siddhartha
    Govindan, Ramaswamy
    JOURNAL OF THORACIC DISEASE, 2022, 14 (05) : 1696 - +
12345